Regional airports like Palm Springs International Airlines are trying to expand international offerings after traffic ...

Amgen's Q4 2024 earnings show a 19% revenue increase year-on-year, with non-GAAP EPS up 13% in Q4 and 6% for the full year.

Kura Oncology and Japan’s Kyowa Kirin have announced that their menin inhibitor ziftomenib met the primary endpoint in a ...

In an editorial, J. Mocco, MD, of Mount Sinai Health System in New York City, characterized the DISTAL and ESCAPE-MeVO ...

Keith Siegel became the first American hostage freed on Saturday as part of an Israel-Hamas ceasefire agreement the U.S.

The following planning applications have been submitted to Mid Sussex District Council, Lewes District Council and the South ...

These are unquestionably serious issues, but Merck remains a top stock to buy and hold, at least for investors focused on the long game. Here's why. Merck's Keytruda generates over $20 billion in ...

The monthly percentage growth of the bitcoin holdings of large investors has accelerated from -0.25% on January 14 to +2% on January 17, the highest monthly rate since mid-December. Such growth ...

VG-3927 Phase 1 trial showed a 50% reduction in sTREM2, favorable safety, and consistent target engagement across genotypes. Vigil Neuroscience plans a Phase 2 trial for Alzheimer's in Q3 2025 ...

Many mid-cap stocks have been delivering stellar gains in the first few weeks of this month, and there’s a good chance the momentum will stick around. I believe they’ll prove to be more nimble ...

It is expected that the company will release topline data from these two ongoing phase 3 VELA-1 and VELA-2 studies in mid-2025. The prior phase 2 MIRA study that was completed by it, showed the ...